Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P L van Riel

Showing results (1-10 of 142) with videos related to

Pageof 15
Sort By:
British Journal of Rheumatology|December 1, 1992
Provisional guidelines for measuring disease activity in clinical trials on rheumatoid arthritisP L van Riel
Nederlands Tijdschrift Voor Geneeskunde|November 26, 1988
[NSAIDs: a clinical pharmacological determination of their role in the drug treatment of rheumatic disorders]P L van Riel
Tijdschrift Voor Ziekenverpleging|June 17, 1986
[Research nurse in rheumatology. A new tree in the forest?]P L van Riel, H A Theunisse
Bailliere'S Clinical Rheumatology|February 1, 1997
Early arthritis: outstanding issuesA D Woolf, P L van Riel
Drug Safety|October 1, 1995
Management of adverse effects of disease-modifying antirheumatic drugsM J Wijnands, P L van Riel
Annals of Medicine|April 1, 1997
Combination of second-line antirheumatic drugsC J Haagsma, P L van Riel
Best Practice & Research. Clinical Rheumatology|May 19, 2001
How does one assess early rheumatoid arthritis in daily clinical practice?P L van Riel, H R Schumacher
Pharmacy World & Science : PWS|June 18, 1993
Quality of life 3. Rheumatoid arthritisP L Van Riel, W G Van Lankveld
Arthritis and Rheumatism|July 21, 2000
Improvement criteria--clinical and statistical significance: comment on the article by Pincus and SteinA M van Gestel, P L van Riel
Annals of the Rheumatic Diseases|October 29, 2000
Clinical outcome measures in rheumatoid arthritisP L van Riel, A M van Gestel
Pageof 15

Showing results (1-10 of 142) with videos related to

Sort By:
Pageof 15
British Journal of Rheumatology|December 1, 1992
Provisional guidelines for measuring disease activity in clinical trials on rheumatoid arthritisP L van Riel
Nederlands Tijdschrift Voor Geneeskunde|November 26, 1988
[NSAIDs: a clinical pharmacological determination of their role in the drug treatment of rheumatic disorders]P L van Riel
Tijdschrift Voor Ziekenverpleging|June 17, 1986
[Research nurse in rheumatology. A new tree in the forest?]P L van Riel, H A Theunisse
Bailliere'S Clinical Rheumatology|February 1, 1997
Early arthritis: outstanding issuesA D Woolf, P L van Riel
Drug Safety|October 1, 1995
Management of adverse effects of disease-modifying antirheumatic drugsM J Wijnands, P L van Riel
Annals of Medicine|April 1, 1997
Combination of second-line antirheumatic drugsC J Haagsma, P L van Riel
Best Practice & Research. Clinical Rheumatology|May 19, 2001
How does one assess early rheumatoid arthritis in daily clinical practice?P L van Riel, H R Schumacher
Pharmacy World & Science : PWS|June 18, 1993
Quality of life 3. Rheumatoid arthritisP L Van Riel, W G Van Lankveld
Arthritis and Rheumatism|July 21, 2000
Improvement criteria--clinical and statistical significance: comment on the article by Pincus and SteinA M van Gestel, P L van Riel
Annals of the Rheumatic Diseases|October 29, 2000
Clinical outcome measures in rheumatoid arthritisP L van Riel, A M van Gestel
Pageof 15